Covered recipient · General Payments record
BRYAN L GARD
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Surgical
General Payments · PY2021–2024
$2,065.87
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $642.33 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $258.82 | 9 |
| IDORSIA PHARMACEUTICALS US INC | $106.45 | 5 |
| PFIZER INC. | $82.60 | 4 |
| Lilly USA, LLC | $82.50 | 4 |
| Novo Nordisk AS | $56.24 | 2 |
| GlaxoSmithKline, LLC. | $22.26 | 1 |
| Currax Pharmaceuticals LLC | $16.76 | 1 |
| Abbott Laboratories | $16.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.70 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125048561 | CMS |
| ABBVIE INC. | $15.04 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107149992 | CMS |
| ABBVIE INC. | $146.72 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107149994 | CMS |
| ABBVIE INC. | $11.74 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107149996 | CMS |
| ABBVIE INC. | $12.68 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107149998 | CMS |
| ABBVIE INC. | $11.02 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107150000 | CMS |
| ABBVIE INC. | $13.86 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107150002 | CMS |
| ABBVIE INC. | $15.24 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107150004 | CMS |
| ABBVIE INC. | $13.73 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107150006 | CMS |
| ABBVIE INC. | $18.79 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107150008 | CMS |
| Currax Pharmaceuticals LLC | $16.76 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089519185 | CMS |
| GlaxoSmithKline, LLC. | $22.26 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116359356 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $22.05 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146767184 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $24.80 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146773192 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $22.35 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146778641 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $19.58 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146787873 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $17.67 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146785196 | CMS |
| Lilly USA, LLC | $20.40 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135594210 | CMS |
| Lilly USA, LLC | $22.72 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135594208 | CMS |
| Lilly USA, LLC | $18.38 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135580222 | CMS |
| Lilly USA, LLC | $21.00 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135580220 | CMS |
| Novo Nordisk Inc | $21.69 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100509303 | CMS |
| Novo Nordisk Inc | $34.55 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100365181 | CMS |
| PFIZER INC. | $21.72 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131919857 | CMS |
| PFIZER INC. | $20.93 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131923569 | CMS |
| PFIZER INC. | $17.76 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131917111 | CMS |
| PFIZER INC. | $22.19 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131987671 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.